ID   S40A1_HUMAN             Reviewed;         571 AA.
AC   Q9NP59; Q6FI62; Q7Z4F8; Q8IVB2; Q9NRL0;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Solute carrier family 40 member 1;
DE   AltName: Full=Ferroportin-1;
DE   AltName: Full=Iron-regulated transporter 1;
GN   Name=SLC40A1; Synonyms=FPN1, IREG1, SLC11A3; ORFNames=MSTP079;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT HFE4
RP   ASP-77.
RX   PubMed=10747949; DOI=10.1074/jbc.M000713200;
RA   Abboud S., Haile D.J.;
RT   "A novel mammalian iron-regulated protein involved in intracellular
RT   iron metabolism.";
RL   J. Biol. Chem. 275:19906-19912(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RX   PubMed=10882071; DOI=10.1016/S1097-2765(00)80425-6;
RA   McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D.,
RA   Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A.,
RA   Hentze M.W., Simpson R.J.;
RT   "A novel duodenal iron-regulated transporter, IREG1, implicated in the
RT   basolateral transfer of iron to the circulation.";
RL   Mol. Cell 5:299-309(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=10693807; DOI=10.1038/35001596;
RA   Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J.,
RA   Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C.,
RA   Lux S.E. IV, Pinkus G.S., Pinkus J.L., Kingsley P.D., Palis J.,
RA   Fleming M.D., Andrews N.C., Zon L.I.;
RT   "Positional cloning of zebrafish ferroportin1 identifies a conserved
RT   vertebrate iron exporter.";
RL   Nature 403:776-781(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-133.
RC   TISSUE=Aorta;
RA   Hui R.T., Zhao B., Sheng H., Qin B.M., Liu Y.Q., Liu B., Wang X.Y.,
RA   Xu H.S., Zhang Q., Tong Y.K., Song L., Ji X.J., Liu B.H., Lu H.,
RA   Chen J.Z., Cai M.Q., Zheng W.Y., Teng C.Y., Liu Q., Yu L.T., Lin J.,
RA   Gong Q., Zhang A.M., Gao R.L.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-6; 16-129 AND 255-316, AND
RP   VARIANT HFE4 VAL-270.
RX   PubMed=15338274; DOI=10.1007/s00439-004-1166-y;
RA   Zaahl M.G., Merryweather-Clarke A.T., Kotze M.J., van der Merwe S.,
RA   Warnich L., Robson K.J.H.;
RT   "Analysis of genes implicated in iron regulation in individuals
RT   presenting with primary iron overload.";
RL   Hum. Genet. 115:409-417(2004).
RN   [12]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, IDENTIFICATION IN A COMPLEX
RP   WITH STOM, AND SUBUNIT.
RX   PubMed=23219802; DOI=10.1016/j.bbamem.2012.11.030;
RA   Rungaldier S., Oberwagner W., Salzer U., Csaszar E., Prohaska R.;
RT   "Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1
RT   in human erythrocyte membrane domains.";
RL   Biochim. Biophys. Acta 1828:956-966(2013).
RN   [13]
RP   VARIANT HFE4 ASP-77.
RX   PubMed=11518736; DOI=10.1172/JCI200113468;
RA   Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E.,
RA   Cassanelli S., Trenor C.C., Gasparini P., Andrews N.C.,
RA   Pietrangelo A.;
RT   "Autosomal-dominant hemochromatosis is associated with a mutation in
RT   the ferroportin (SLC11A3) gene.";
RL   J. Clin. Invest. 108:619-623(2001).
RN   [14]
RP   VARIANT HFE4 HIS-144.
RX   PubMed=11431687; DOI=10.1038/90038;
RA   Njajou O.T., Vaessen N., Joosse M., Berghuis B., van Dongen J.W.F.,
RA   Breuning M.H., Snijders P.J.L.M., Rutten W.P.F., Sandkuijl L.A.,
RA   Oostra B.A., van Duijn C.M., Heutink P.;
RT   "A mutation in SLC11A3 is associated with autosomal dominant
RT   hemochromatosis.";
RL   Nat. Genet. 28:213-214(2001).
RN   [15]
RP   VARIANT HFE4 VAL-162 DEL.
RX   PubMed=12091366; DOI=10.1182/blood.V100.2.692;
RA   Wallace D.F., Pedersen P., Dixon J.L., Stephenson P., Searle J.W.,
RA   Powell L.W., Subramaniam V.N.;
RT   "Novel mutation in ferroportin1 is associated with autosomal dominant
RT   hemochromatosis.";
RL   Blood 100:692-694(2002).
RN   [16]
RP   VARIANT HFE4 VAL-162 DEL.
RX   PubMed=12091367; DOI=10.1182/blood-2001-11-0132;
RA   Devalia V., Carter K., Walker A.P., Perkins S.J., Worwood M., May A.,
RA   Dooley J.S.;
RT   "Autosomal dominant reticuloendothelial iron overload associated with
RT   a 3-base pair deletion in the ferroportin 1 gene (SLC11A3).";
RL   Blood 100:695-697(2002).
RN   [17]
RP   VARIANT HFE4 VAL-162 DEL.
RX   PubMed=12123233; DOI=10.1182/blood-2002-03-0693;
RA   Roetto A., Merryweather-Clarke A.T., Daraio F., Livesey K.,
RA   Pointon J.J., Barbabietola G., Piga A., Mackie P.H., Robson K.J.H.,
RA   Camaschella C.;
RT   "A valine deletion of ferroportin 1: a common mutation in
RT   hemochromastosis type 4.";
RL   Blood 100:733-734(2002).
RN   [18]
RP   VARIANT HFE4 VAL-162 DEL.
RX   PubMed=12406098; DOI=10.1046/j.1365-2141.2002.03946.x;
RA   Cazzola M., Cremonesi L., Papaioannou M., Soriani N., Kioumi A.,
RA   Charalambidou A., Paroni R., Romtsou K., Levi S., Ferrari M.,
RA   Arosio P., Christakis J.;
RT   "Genetic hyperferritinaemia and reticuloendothelial iron overload
RT   associated with a three base pair deletion in the coding region of the
RT   ferroportin gene (SLC11A3).";
RL   Br. J. Haematol. 119:539-546(2002).
RN   [19]
RP   VARIANTS HFE4 GLY-157; HIS-182 AND VAL-323.
RX   PubMed=12730114; DOI=10.1182/blood-2003-02-0439;
RA   Hetet G., Devaux I., Soufir N., Grandchamp B., Beaumont C.;
RT   "Molecular analyses of patients with hyperferritinemia and normal
RT   serum iron values reveal both L ferritin IRE and 3 new ferroportin
RT   (SLC11A3) mutations.";
RL   Blood 102:1904-1910(2003).
RN   [20]
RP   VARIANT HIS-248.
RX   PubMed=14636642; DOI=10.1016/S1079-9796(03)00164-5;
RA   Gordeuk V.R., Caleffi A., Corradini E., Ferrara F., Jones R.A.,
RA   Castro O., Onyekwere O., Kittles R., Pignatti E., Montosi G.,
RA   Garuti C., Gangaidzo I.T., Gomo Z.A.R., Moyo V.M., Rouault T.A.,
RA   MacPhail P., Pietrangelo A.;
RT   "Iron overload in Africans and African-Americans and a common mutation
RT   in the SCL40A1 (ferroportin 1) gene.";
RL   Blood Cells Mol. Dis. 31:299-304(2003).
RN   [21]
RP   VARIANT HFE4 THR-144.
RX   PubMed=12865285; DOI=10.1136/gut.52.8.1215;
RA   Arden K.E., Wallace D.F., Dixon J.L., Summerville L., Searle J.W.,
RA   Anderson G.J., Ramm G.A., Powell L.W., Subramaniam V.N.;
RT   "A novel mutation in ferroportin1 is associated with haemochromatosis
RT   in a Solomon Islands patient.";
RL   Gut 52:1215-1217(2003).
RN   [22]
RP   VARIANT HFE4 ASN-64.
RX   PubMed=12857562;
RA   Rivard S.R., Lanzara C., Grimard D., Carella M., Simard H.,
RA   Ficarella R., Simard R., D'Adamo A.P., De Braekeleer M., Gasparini P.;
RT   "Autosomal dominant reticuloendothelial iron overload (HFE type 4) due
RT   to a new missense mutation in the FERROPORTIN 1 gene (SLC11A3) in a
RT   large French-Canadian family.";
RL   Haematologica 88:824-826(2003).
RN   [23]
RP   VARIANT IRON OVERLOAD ASP-490.
RX   PubMed=12873829; DOI=10.1016/S0168-8278(03)00148-X;
RA   Jouanolle A.-M., Douabin-Gicquel V., Halimi C., Loreal O.,
RA   Fergelot P., Delacour T., de Lajarte-Thirouard A.-S., Turlin B.,
RA   Le Gall J.-Y., Cadet E., Rochette J., David V., Brissot P.;
RT   "Novel mutation in ferroportin 1 gene is associated with autosomal
RT   dominant iron overload.";
RL   J. Hepatol. 39:286-289(2003).
RN   [24]
RP   VARIANTS IRON OVERLOAD SER-80 AND ILE-174.
RX   PubMed=14757427; DOI=10.1016/j.bcmd.2003.08.003;
RA   Pietrangelo A.;
RT   "The ferroportin disease.";
RL   Blood Cells Mol. Dis. 32:131-138(2004).
RN   [25]
RP   VARIANTS HFE4 ASP-144 AND VAL-270, AND VARIANT IRON OVERLOAD TYR-326.
RX   PubMed=15466004; DOI=10.1136/jmg.2004.020644;
RA   Robson K.J.H., Merryweather-Clarke A.T., Cadet E., Viprakasit V.,
RA   Zaahl M.G., Pointon J.J., Weatherall D.J., Rochette J.;
RT   "Recent advances in understanding haemochromatosis: a transition
RT   state.";
RL   J. Med. Genet. 41:721-730(2004).
RN   [26]
RP   ERRATUM.
RA   Robson K.J.H., Merryweather-Clarke A.T., Cadet E., Viprakasit V.,
RA   Zaahl M.G., Pointon J.J., Weatherall D.J., Rochette J.;
RL   J. Med. Genet. 41:959-959(2004).
RN   [27]
RP   VARIANTS HFE4 VAL-80; VAL-181 AND ASP-267.
RX   PubMed=16351644; DOI=10.1111/j.1365-2141.2005.05815.x;
RA   Cremonesi L., Forni G.L., Soriani N., Lamagna M., Fermo I., Daraio F.,
RA   Galli A., Pietra D., Malcovati L., Ferrari M., Camaschella C.,
RA   Cazzola M.;
RT   "Genetic and clinical heterogeneity of ferroportin disease.";
RL   Br. J. Haematol. 131:663-670(2005).
RN   [28]
RP   ERRATUM.
RA   Cremonesi L., Forni G.L., Soriani N., Lamagna M., Fermo I., Daraio F.,
RA   Galli A., Pietra D., Malcovati L., Ferrari M., Camaschella C.,
RA   Cazzola M.;
RL   Br. J. Haematol. 132:806-806(2006).
CC   -!- FUNCTION: May be involved in iron export from duodenal epithelial
CC       cell and also in transfer of iron between maternal and fetal
CC       circulation. Mediates iron efflux in the presence of a ferroxidase
CC       (hephaestin and/or ceruloplasmin).
CC   -!- SUBUNIT: Identified in a complex with STOM.
CC       {ECO:0000269|PubMed:23219802}.
CC   -!- INTERACTION:
CC       P05067:APP; NbExp=5; IntAct=EBI-725153, EBI-77613;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10882071,
CC       ECO:0000269|PubMed:23219802}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10882071, ECO:0000269|PubMed:23219802}.
CC       Note=Localized to the basolateral membrane of polarized epithelial
CC       cells.
CC   -!- TISSUE SPECIFICITY: Detected in erythrocytes (at protein level).
CC       Expressed in placenta, intestine, muscle and spleen.
CC       {ECO:0000269|PubMed:10747949, ECO:0000269|PubMed:23219802}.
CC   -!- DISEASE: Hemochromatosis 4 (HFE4) [MIM:606069]: A disorder of iron
CC       metabolism characterized by iron overload. Excess iron is
CC       deposited in a variety of organs leading to their failure, and
CC       resulting in serious illnesses including cirrhosis, hepatomas,
CC       diabetes, cardiomyopathy, arthritis, and hypogonadotropic
CC       hypogonadism. Severe effects of the disease usually do not appear
CC       until after decades of progressive iron loading.
CC       {ECO:0000269|PubMed:10747949, ECO:0000269|PubMed:11431687,
CC       ECO:0000269|PubMed:11518736, ECO:0000269|PubMed:12091366,
CC       ECO:0000269|PubMed:12091367, ECO:0000269|PubMed:12123233,
CC       ECO:0000269|PubMed:12406098, ECO:0000269|PubMed:12730114,
CC       ECO:0000269|PubMed:12857562, ECO:0000269|PubMed:12865285,
CC       ECO:0000269|PubMed:15338274, ECO:0000269|PubMed:15466004,
CC       ECO:0000269|PubMed:16351644}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ferroportin (FP) (TC 2.A.100) family.
CC       SLC40A subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF215636; AAF80986.1; -; mRNA.
DR   EMBL; AF231121; AAF44330.1; -; mRNA.
DR   EMBL; AF226614; AAF36697.1; -; mRNA.
DR   EMBL; AL136944; CAB66878.1; -; mRNA.
DR   EMBL; AK314827; BAG37348.1; -; mRNA.
DR   EMBL; CR533564; CAG38595.1; -; mRNA.
DR   EMBL; AC013439; AAX93082.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10902.1; -; Genomic_DNA.
DR   EMBL; BC035893; AAH35893.1; -; mRNA.
DR   EMBL; BC037733; AAH37733.1; -; mRNA.
DR   EMBL; AF171087; AAQ13603.1; -; mRNA.
DR   EMBL; AJ604512; CAE53170.1; -; Genomic_DNA.
DR   EMBL; AJ609539; CAE81347.1; -; Genomic_DNA.
DR   EMBL; AJ609540; CAE81348.1; -; Genomic_DNA.
DR   EMBL; AJ616848; CAE83578.1; -; Genomic_DNA.
DR   EMBL; AJ616847; CAE83578.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS2299.1; -.
DR   RefSeq; NP_055400.1; NM_014585.5.
DR   UniGene; Hs.643005; -.
DR   ProteinModelPortal; Q9NP59; -.
DR   IntAct; Q9NP59; 5.
DR   MINT; MINT-1404238; -.
DR   STRING; 9606.ENSP00000261024; -.
DR   BindingDB; Q9NP59; -.
DR   ChEMBL; CHEMBL3392948; -.
DR   TCDB; 2.A.100.1.4; the ferroportin (fpn) family.
DR   iPTMnet; Q9NP59; -.
DR   PhosphoSitePlus; Q9NP59; -.
DR   BioMuta; SLC40A1; -.
DR   DMDM; 48428687; -.
DR   PaxDb; Q9NP59; -.
DR   PeptideAtlas; Q9NP59; -.
DR   PRIDE; Q9NP59; -.
DR   DNASU; 30061; -.
DR   Ensembl; ENST00000261024; ENSP00000261024; ENSG00000138449.
DR   GeneID; 30061; -.
DR   KEGG; hsa:30061; -.
DR   UCSC; uc002uqp.5; human.
DR   CTD; 30061; -.
DR   DisGeNET; 30061; -.
DR   GeneCards; SLC40A1; -.
DR   HGNC; HGNC:10909; SLC40A1.
DR   HPA; HPA065634; -.
DR   MalaCards; SLC40A1; -.
DR   MIM; 604653; gene.
DR   MIM; 606069; phenotype.
DR   neXtProt; NX_Q9NP59; -.
DR   OpenTargets; ENSG00000138449; -.
DR   Orphanet; 139491; Hemochromatosis type 4.
DR   PharmGKB; PA35805; -.
DR   eggNOG; KOG2601; Eukaryota.
DR   eggNOG; ENOG410XS3F; LUCA.
DR   GeneTree; ENSGT00390000015143; -.
DR   HOGENOM; HOG000234273; -.
DR   HOVERGEN; HBG055582; -.
DR   InParanoid; Q9NP59; -.
DR   KO; K14685; -.
DR   OMA; CLTLCVI; -.
DR   OrthoDB; EOG091G06RI; -.
DR   PhylomeDB; Q9NP59; -.
DR   TreeFam; TF313463; -.
DR   Reactome; R-HSA-425410; Metal ion SLC transporters.
DR   Reactome; R-HSA-917937; Iron uptake and transport.
DR   ChiTaRS; SLC40A1; human.
DR   GeneWiki; Ferroportin; -.
DR   GenomeRNAi; 30061; -.
DR   PRO; PR:Q9NP59; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000138449; -.
DR   CleanEx; HS_SLC40A1; -.
DR   ExpressionAtlas; Q9NP59; baseline and differential.
DR   Genevisible; Q9NP59; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0005887; C:integral component of plasma membrane; IC:BHF-UCL.
DR   GO; GO:0005622; C:intracellular; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; IEA:Ensembl.
DR   GO; GO:0015093; F:ferrous iron transmembrane transporter activity; ISS:BHF-UCL.
DR   GO; GO:0097689; F:iron channel activity; ISS:BHF-UCL.
DR   GO; GO:0005381; F:iron ion transmembrane transporter activity; IMP:BHF-UCL.
DR   GO; GO:0017046; F:peptide hormone binding; IPI:BHF-UCL.
DR   GO; GO:0004872; F:receptor activity; ISS:BHF-UCL.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IMP:BHF-UCL.
DR   GO; GO:0003158; P:endothelium development; IEA:Ensembl.
DR   GO; GO:1903988; P:ferrous iron export across plasma membrane; ISS:BHF-UCL.
DR   GO; GO:0034755; P:iron ion transmembrane transport; IMP:BHF-UCL.
DR   GO; GO:0002260; P:lymphocyte homeostasis; IEA:Ensembl.
DR   GO; GO:0060586; P:multicellular organismal iron ion homeostasis; ISS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0034395; P:regulation of transcription from RNA polymerase II promoter in response to iron; IEA:Ensembl.
DR   GO; GO:0060345; P:spleen trabecula formation; IEA:Ensembl.
DR   InterPro; IPR009716; Ferroportin-1.
DR   InterPro; IPR020846; MFS_dom.
DR   Pfam; PF06963; FPN1; 1.
DR   SUPFAM; SSF103473; SSF103473; 3.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disease mutation; Glycoprotein;
KW   Ion transport; Iron; Iron transport; Membrane; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    571       Solute carrier family 40 member 1.
FT                                /FTId=PRO_0000191310.
FT   TRANSMEM     12     34       Helical. {ECO:0000255}.
FT   TRANSMEM     58     80       Helical. {ECO:0000255}.
FT   TRANSMEM     93    115       Helical. {ECO:0000255}.
FT   TRANSMEM    125    147       Helical. {ECO:0000255}.
FT   TRANSMEM    299    321       Helical. {ECO:0000255}.
FT   TRANSMEM    341    363       Helical. {ECO:0000255}.
FT   TRANSMEM    370    392       Helical. {ECO:0000255}.
FT   TRANSMEM    450    472       Helical. {ECO:0000255}.
FT   TRANSMEM    492    514       Helical. {ECO:0000255}.
FT   TRANSMEM    519    541       Helical. {ECO:0000255}.
FT   CARBOHYD    174    174       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    567    567       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      64     64       Y -> N (in HFE4).
FT                                {ECO:0000269|PubMed:12857562}.
FT                                /FTId=VAR_030057.
FT   VARIANT      77     77       A -> D (in HFE4; dbSNP:rs28939076).
FT                                {ECO:0000269|PubMed:10747949,
FT                                ECO:0000269|PubMed:11518736}.
FT                                /FTId=VAR_022594.
FT   VARIANT      80     80       G -> S (in iron overload).
FT                                {ECO:0000269|PubMed:14757427}.
FT                                /FTId=VAR_030058.
FT   VARIANT      80     80       G -> V (in HFE4; dbSNP:rs104893673).
FT                                {ECO:0000269|PubMed:16351644}.
FT                                /FTId=VAR_030059.
FT   VARIANT     144    144       N -> D (in HFE4).
FT                                {ECO:0000269|PubMed:15466004}.
FT                                /FTId=VAR_030060.
FT   VARIANT     144    144       N -> H (in HFE4; dbSNP:rs104893662).
FT                                {ECO:0000269|PubMed:11431687}.
FT                                /FTId=VAR_022595.
FT   VARIANT     144    144       N -> T (in HFE4).
FT                                {ECO:0000269|PubMed:12865285}.
FT                                /FTId=VAR_030061.
FT   VARIANT     157    157       D -> G (in HFE4; dbSNP:rs104893663).
FT                                {ECO:0000269|PubMed:12730114}.
FT                                /FTId=VAR_022596.
FT   VARIANT     162    162       Missing (in HFE4).
FT                                {ECO:0000269|PubMed:12091366,
FT                                ECO:0000269|PubMed:12091367,
FT                                ECO:0000269|PubMed:12123233,
FT                                ECO:0000269|PubMed:12406098}.
FT                                /FTId=VAR_022597.
FT   VARIANT     174    174       N -> I (in iron overload).
FT                                {ECO:0000269|PubMed:14757427}.
FT                                /FTId=VAR_030062.
FT   VARIANT     181    181       D -> V (in HFE4; dbSNP:rs104893672).
FT                                {ECO:0000269|PubMed:16351644}.
FT                                /FTId=VAR_030063.
FT   VARIANT     182    182       Q -> H (in HFE4; dbSNP:rs104893670).
FT                                {ECO:0000269|PubMed:12730114}.
FT                                /FTId=VAR_022598.
FT   VARIANT     248    248       Q -> H (common polymorphism associated
FT                                with mild anemia and a tendency to iron
FT                                loading; dbSNP:rs11568350).
FT                                {ECO:0000269|PubMed:14636642}.
FT                                /FTId=VAR_020295.
FT   VARIANT     267    267       G -> D (in HFE4; dbSNP:rs104893664).
FT                                {ECO:0000269|PubMed:16351644}.
FT                                /FTId=VAR_030064.
FT   VARIANT     270    270       D -> V (in HFE4; dbSNP:rs368420430).
FT                                {ECO:0000269|PubMed:15338274,
FT                                ECO:0000269|PubMed:15466004}.
FT                                /FTId=VAR_030065.
FT   VARIANT     323    323       G -> V (in HFE4; dbSNP:rs104893671).
FT                                {ECO:0000269|PubMed:12730114}.
FT                                /FTId=VAR_022599.
FT   VARIANT     326    326       C -> Y (in iron overload).
FT                                {ECO:0000269|PubMed:15466004}.
FT                                /FTId=VAR_030066.
FT   VARIANT     432    432       M -> V (in dbSNP:rs11568355).
FT                                /FTId=VAR_020296.
FT   VARIANT     443    443       P -> L (in dbSNP:rs45606432).
FT                                /FTId=VAR_029299.
FT   VARIANT     490    490       G -> D (in iron overload).
FT                                {ECO:0000269|PubMed:12873829}.
FT                                /FTId=VAR_030067.
FT   VARIANT     561    561       R -> G (in dbSNP:rs11568346).
FT                                /FTId=VAR_018980.
FT   CONFLICT    130    133       TSCY -> VSSQ (in Ref. 10; AAQ13603).
FT                                {ECO:0000305}.
FT   CONFLICT    324    324       F -> S (in Ref. 9; AAH35893).
FT                                {ECO:0000305}.
FT   CONFLICT    430    431       IY -> RD (in Ref. 1; AAF80986).
FT                                {ECO:0000305}.
SQ   SEQUENCE   571 AA;  62542 MW;  E4D6B5594C904959 CRC64;
     MTRAGDHNRQ RGCCGSLADY LTSAKFLLYL GHSLSTWGDR MWHFAVSVFL VELYGNSLLL
     TAVYGLVVAG SVLVLGAIIG DWVDKNARLK VAQTSLVVQN VSVILCGIIL MMVFLHKHEL
     LTMYHGWVLT SCYILIITIA NIANLASTAT AITIQRDWIV VVAGEDRSKL ANMNATIRRI
     DQLTNILAPM AVGQIMTFGS PVIGCGFISG WNLVSMCVEY VLLWKVYQKT PALAVKAGLK
     EEETELKQLN LHKDTEPKPL EGTHLMGVKD SNIHELEHEQ EPTCASQMAE PFRTFRDGWV
     SYYNQPVFLA GMGLAFLYMT VLGFDCITTG YAYTQGLSGS ILSILMGASA ITGIMGTVAF
     TWLRRKCGLV RTGLISGLAQ LSCLILCVIS VFMPGSPLDL SVSPFEDIRS RFIQGESITP
     TKIPEITTEI YMSNGSNSAN IVPETSPESV PIISVSLLFA GVIAARIGLW SFDLTVTQLL
     QENVIESERG IINGVQNSMN YLLDLLHFIM VILAPNPEAF GLLVLISVSF VAMGHIMYFR
     FAQNTLGNKL FACGPDAKEV RKENQANTSV V
//
